Most common adverse reactions (≥ 20%) are upper respiratory tract infections, musculoskeletal pain, fatigue, nausea, rash, and diarrhea. Most common laboratory abnormalities (≥ 20%) are platelet count decreased, triglycerides increased, neutrophil count decreased, hemoglobin decreased, creatine kinase increased, alanine aminotransferase increased, lipase increased, and amylase increased.
from FDA,2021.10
All medications may be associated with certain adverse reactions, and asciminib ···【more】
Release date:2026-03-31Recommended:47